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Abstract  28 
Shifts in cellular metabolic phenotypes have the potential to cause disease-driving processes 29 
in respiratory disease. The respiratory epithelium is particularly susceptible to metabolic shifts 30 
in disease, but our understanding of these processes are limited by the incompatibility of the 31 
technology required to measure metabolism in real-time with the cell culture platforms used to 32 
generate differentiated respiratory epithelial cell types. Thus to date, our understanding of 33 
respiratory epithelial metabolism has been restricted to that of basal epithelial cells in 34 
submerged culture, or via indirect endpoint metabolomics readouts in lung tissue. Here we 35 
present a novel methodology using the widely available Seahorse Analyzer platform to monitor 36 
real-time changes in the cellular metabolism of fully differentiated primary human airway 37 
epithelial cells grown at air-liquid interface (ALI). We show increased glycolytic, but not 38 
mitochondrial, ATP production rates in response to physiologically relevant increases in 39 
glucose availability. We also show that pharmacological inhibition of lactate dehydrogenase is 40 
able to reduce glucose-induced shifts towards aerobic glycolysis. This method is timely given 41 
the recent advances in our understanding of new respiratory epithelial subtypes that can only 42 
be observed in vitro through culture at ALI and will open new avenues to measure real-time 43 
metabolic changes in healthy and diseased respiratory epithelium, and in turn the potential for 44 
the development of novel therapeutics targeting metabolic-driven disease phenotypes. 45 
  46 
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Introduction 47 
Metabolic phenotypes are influenced by a number of genetic and environmental factors 48 
including gender, age, diet, microbiome, exercise, hormones and medication. Each unique 49 
combination, and therefore unique metabolic phenotype, can determine the disease risk of an 50 
individual. This is of particular importance in respiratory disease research; recent studies have 51 
demonstrated that altered metabolic phenotypes can modulate disease-driving cellular 52 
processes prevalent in the pathologies of chronic lung diseases, such as cellular proliferation, 53 
differentiation, apoptosis, autophagy, senescence and inflammation (12, 28, 29). Despite the 54 
high metabolic activity of the lung, with glucose metabolism in particular surpassing that of 55 
many other organs (12), our understanding of metabolic dysfunction as a driver or 56 
consequence of respiratory disease pathology is limited.  57 
Much of the lung’s metabolic activity occurs in the epithelium where cells have dense apical 58 
concentrations of mitochondria and carry out energy demanding processes such as 59 
mucin/surfactant production and mucociliary clearance (27). The respiratory epithelium 60 
provides a barrier to prevent nutrients entering the respiratory tract from the interstitium/blood 61 
and through tight control of glucose transport the glucose concentration in the airway is 62 
maintained at 3-20-fold lower than in plasma (6). In healthy airway epithelium, glucose is 63 
rapidly processed by hexokinase-dependent and -independent metabolic pathways to 64 
maintain low intracellular glucose concentrations (1). However, airway glucose concentrations 65 
are elevated in respiratory disease and hyperglycaemia, which is associated with increased 66 
risk of respiratory infection (2, 18, 19). Thus understanding the metabolic processes underlying 67 
lung metabolite homeostasis in health and disease could identify new therapeutic targets for 68 
the treatment of lung infections. The Seahorse platform is an excellent tool for interrogating 69 
cellular metabolism, measuring oxygen consumption rate (OCR) and extracellular acidification 70 
rate (ECAR), in real time. Recent studies modelling the human airway epithelium have utilised 71 
this technology to show how mitochondrial dysfunction, caused by cigarettes and e-cigarettes, 72 
might contribute to the pathology of lung disease (3, 23) as well as investigating how infection 73 
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influences epithelial cell metabolism (13). While these studies all provide key information on 74 
airway cell metabolism, the data is all generated using epithelial cells grown in submerged 75 
cultures. Accordingly, a methodological development to monitor real time metabolic changes 76 
of fully differentiated airway epithelial cells, under a range of conditions, would be of particular 77 
benefit to the field of respiratory research.  78 
Since Whitcutt et al (25) first described a method to grow airway epithelial cells at an air-liquid-79 
interface (ALI) this has become widely used to investigate epithelial barrier function.  ALI 80 
cultures are an excellent research resource as once the cells fully differentiate they have a 81 
range of features which are not present in undifferentiated cells (25). They form polarised 82 
barriers with characteristic epithelial ion transport properties and contain a heterogeneous cell 83 
population of secretory and ciliated cells which only become apparent in vitro when the cells 84 
are maintained at ALI. Recent single cell profiling has further demonstrated the heterogeneity 85 
of ALI cultures at a molecular level and allowed the authors to identify a rare and novel 86 
epithelial cell type, the pulmonary ionocyte (20). This highlights the importance of studying a 87 
heterogeneous mixture of differentiated cells, which makes our exploration of epithelial 88 
metabolism in ALI cultures particularly timely. 89 
There are very few studies which have attempted to measure cellular metabolism in 90 
differentiated airway epithelial cells, and the only report which we are aware required the in-91 
house manufacture of cell culture equipment (27), which is beyond the resources of many 92 
researchers. We describe a novel method utilising the Seahorse XF24 Analyzer platform to 93 
monitor real time changes in the cellular bioenergetics of human airway epithelial cells fully 94 
differentiated at an air-liquid-interface. We describe a simple protocol, predicated on 95 
inexpensive and widely available equipment. 96 
 97 
  98 
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Methods 99 
Sample source 100 
We obtained approval for the collection of clinical waste material obtained during routine nasal 101 
surgical procedures [Newcastle Biobank application NB-169, Research Ethics Committee 102 
Reference 17/NE/0361]. Written informed consent was obtained from all participants.  103 
Epithelial cell culture at air-liquid interface (ALI) 104 
Primary human airway epithelial cells were isolated from clinical waste material obtained 105 
during routine nasal surgical procedures. Chopped sections of epithelial tissue (approx. 1mm3) 106 
were cultured in PneumaCult™-Ex Plus Medium (STEMCELL Technologies) for 7-9 days in 107 
Type I collagen coated flasks (Purecol 30 µg/ml). P1 cells were then transferred onto collagen 108 
coated  0.4μm pore size transwells (Costar) at 150,000 cells/cm2. Once the cells were fully 109 
confluent (2-4 days) apical media was removed and basolateral media was switched to 110 
PneumaCult™-ALI version 2 custom medium (STEMCELL Technologies) and the cells were 111 
maintained at ALI until fully differentiated (25). Barrier integrity of ALI cultures was monitored 112 
by measuring trans-epithelial electrical resistance (EVOM 2, World Precision Instruments) and 113 
ion channel function assessed using Ussing chamber short circuit current measurements. 114 
Transwells were routinely fixed with 2% glutaraldehyde for TEM/SEM (Newcastle University 115 
Electron Microscopy Research Services) and 4% PFA for H&E staining (NHS Cellular 116 
Pathology, RVI Newcastle). 117 
Seahorse XF24 Analyzer 118 
All reagents were obtained from Sigma, unless stated otherwise. Apical washes, with pre-119 
warmed PBS, of the ALI cultures were carried out 24 hours prior to all seahorse experiments.  120 
Sections of ALI cultures on Transwells were cut from the membrane using a 3 mm punch 121 
biopsy (Kai Medical). These were carefully loaded into a seahorse islet capture plate (Agilent 122 
Technologies) and held in place with the islet capture grid (Figure 2). Wells were loaded with 123 
Downloaded from journals.physiology.org/journal/ajplung (086.186.050.195) on May 15, 2020.
6 
 
 
450 μl experimental media (DMEM without NaHCO3, glucose or phenol red (Sigma), 124 
supplemented with 1 mM D-glucose and 2 mM L-glutamine, pH 7.4 at 37°C). The plate was 125 
incubated at 37˚C without CO2 while the cartridge was loaded and calibrated in XF24 126 
Seahorse Analyzer (Agilent).  127 
Cellular energetics for ATP production rates by mitochondrial oxidative phosphorylation and 128 
glycolysis were calculated by using the OCR and ECAR (16). Un-buffered medium enables 129 
the Seahorse Analyzer to accurately detect changes in acidification rates of the medium, as 130 
lactate secretion associated with glycolysis causes an acidification of the medium. Changes 131 
in OCR, after sequential inhibition of different stages of the electron transport chain, are used 132 
to measure mitochondrial ATP production (16). Oligomycin inhibits ATP synthase, thus 133 
oligomycin-induced changes in OCR reflect the oxygen consumption due to mitochondrial 134 
ATP production, which is used to calculate the mitochondrial ATP production rates. Carbonyl 135 
cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) is an uncoupler, hence stimulating 136 
electron transport chain and increasing OCR. Rotenone and Antimycin A, complex I and 137 
complex III inhibitors respectively, block electron transport activity and hence mitochondrial 138 
OCR and the OCR in the presence of them indicates non-mitochondrial respiration. 139 
Injection ports for the cartridge were prepared in experimental buffer as follows. Injection port 140 
A with 50 μl of 1 mM, 14 mM or 140 mM D glucose (final concentrations to be 1 mM, 5 mM or 141 
15 mM). Injection port B with 55 μl of 50 μg/ml oligomycin (final concentration 5 μg/ml as 142 
determined by titration shown in Figure 3). Injection port C with 60 μl of 25 μM FCCP (final 143 
concentration 2.5 μM, as determined by titration in Figure 3) and injection port D with 65 μl of 144 
25 μM Antimycin A and 5 μM Rotenone (final concentrations 2.5 μM and 0.5 μM respectively). 145 
LDH5 inhibitor (synthesized according to the procedures described in patent WO 2015/140133 146 
A1 (22)) was injected to a final concentration of 30 µM per well using DMSO vehicle control 147 
where appropriate.  148 
Cycles of; mix (2 minutes), wait (1 minute), measure (3 minutes) were used. After our 149 
optimisation experiments we allowed 5 cycles for the cells to equilibrate, 7 cycles following 150 
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glucose injection, 11 cycles after oligomycin, 7 cycles after FCCP and 6 cycles following 151 
antimycin A and Rotenone addition. For LDH5 inhibition assays we allowed 5 cycles for 152 
equilibration, 7 cycles following glucose injection (port A), 13 cycles each following LHD5inh 153 
injection (port B) and oligomycin (port C) with a final 7 cycles after antimycin A and Rotenone 154 
(port D) injection. 155 
Data analysis to calculate absolute ATP production rates was carried out using the methods 156 
described by Mookerjee and Brand (16), taking into account the acidification rates due to 157 
mitochondrial CO2 production. All statistical analysis was carried out using GraphPad Prism 158 
8. 159 
  160 
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Results 161 
Culture of ALI epithelial cells 162 
Primary human nasal epithelial cells were successfully grown at ALI to form fully differentiated 163 
pseudostratified cultures (Figure 1A). Cilia were visible on the apical side (Figure 1A) and cells 164 
were shown to contain a large number of apical mitochondria (Figure 1A). Our ALI cultures 165 
showed electrophysiological polarisation and had characteristic ion transport systems as 166 
measured in an Ussing system (Figure 1B). The initial short circuit current (Isc) was completely 167 
inhibited by amiloride (10 µM) indicating that this standing Isc is carried by apical to basolateral 168 
Na+ transport through apical epithelial sodium channels (ENaC). Further addition of forskolin 169 
(10 µM) generated a positive Isc which reached a plateau and was fully reversed with 170 
CFTRinh-172, indicating apical Cl- secretion via CFTR channels. Finally, addition of ATP (100 171 
µM) generated a further positive Isc (which decayed spontaneously). This is likely to be Cl- 172 
efflux through apical Ca2+-activated Cl- channels, activated by intracellular Ca2+ pulse (initiated 173 
via ATP interaction with apical P2Y receptors). 174 
Seahorse Analyzer protocol optimisation 175 
Sections of membrane with cells attached were loaded into the seahorse islet plate and held 176 
in place with the islet capture grid (Figure 2). We compared the oxygen consumption rate 177 
(OCR) and extracellular acidification rate (ECAR) values when cells were loaded into the islet 178 
plate with the cells either facing up or down. Significantly higher values for both OCR and 179 
ECAR were obtained when cells were facing up (Figure 3A). Therefore, it was decided that for 180 
all subsequent experiments disks of membrane would be loaded into the plate with the cells 181 
facing up. Epithelial cells remained attached to the membrane throughout the experiment as 182 
verified by visual inspection with brightfield microscopy.  183 
Oligomycin concentrations ranging from 2.5-10 µM were tested. Each concentration was 184 
sufficient to induce a decrease in OCR as mitochondrial ATP synthesis was inhibited. The 185 
maximum change in OCR was seen in 5 µg/ml oligomycin without further decrease at 10 µg/ml 186 
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(Figure 3B), therefore 5 µg/ml was selected for all subsequent experiments. The FCCP 187 
concentration to induce maximum OCR was also determined (1.5 –3.5 µM) and it was found 188 
2.5 µM FCCP was sufficient to achieve the highest increase in OCR (Figure 3C).  Importantly, 189 
we found that it takes much longer for the pseudostratified cultures to achieve steady state 190 
after glucose and drug injections than a simple monolayer of airway epithelial cells (7).   191 
ALI cultures at altered glucose concentrations 192 
Once experimental conditions had been optimised we tested the bioenergetic response of our 193 
differentiated airway epithelial cells to altered glucose concentrations. We saw that following 194 
addition of both 5 mM and 15 mM D-glucose levels of ECAR significantly increased, when 195 
compared to 1 mM glucose while no changes were observed in OCRs in any of the glucose 196 
concentrations (Figure 4A). Therefore, assuming mitochondrial CO2 production rates also 197 
remained the same, the changes in ECAR under these conditions would reflect the glycolysis 198 
dependent medium acidification rate. Following addition of oligomycin the greatest decrease 199 
in OCR was seen in the 1mM glucose samples.  200 
Analysis of absolute ATP production rates showed that increasing the glucose concentration 201 
causes a significant and progressive increase in ATP production by glycolysis from 252 202 
pmol/min at 1 mM to 703 pmol/min at 5 mM and 952 pmol/min at 15 mM (Figure 4B). While 203 
glycolytic ATP production rates increased with increasing levels of glucose, we saw that 204 
mitochondrial (OXPHOS) ATP production rates significantly decreased from 798 pmol/min at 205 
1 mM to 487 pmol/min at 5 mM and 362 pmol/min at 15 mM. There was no statistically 206 
significant difference in OXPHOS ATP production rates between the 5 mM and 15 mM glucose 207 
concentrations.  208 
Proof-of-concept: inhibition of LDH suppresses glucose-induced extracellular acidification 209 
Multiple chronic lung diseases, including COPD, CF and IPF are associated with elevated lung 210 
lactate concentrations (26, 29), with the metabolic shifts towards glycolysis in the epithelium 211 
being at least in part implicated in these observed changes (7). In order to suppress lactate 212 
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production by glycolysis in our fully differentiated ALI cultures we injected an inhibitor of lactate 213 
dehydrogenase 5 (LDH5; Compound 408, Genentech; Figure 4C(22)). At all glucose 214 
concentrations there was significant decrease in the maximum ECAR following LDH5 inhibitor 215 
addition, with the greatest decrease at the highest concentration of 15 mM Glucose (Figure 216 
4D). Therefore, we have demonstrated empirically that LDH5 inhibition indeed lowered 217 
glycolytic activity of the cells.  218 
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Discussion 219 
Our study presents a robust, practicable methodology that allows the metabolic 220 
characterisation of differentiated primary human airway epithelial cell cultures using the widely 221 
available Seahorse XF24 Analyzer platform. This allows multi-well measurements of real time 222 
oxygen consumption and extracellular acidification rates in live cells, providing information on 223 
glycolysis and mitochondrial function. To our knowledge this is the first time this has been 224 
possible using commercially available equipment. 225 
This study used primary nasal epithelial cells as an exemplar for methodology development, 226 
due to their ability to replicate complex airway architecture in vitro (8). However, contrary to 227 
the previously proposed airways model (21), it is clear that there are differences between the 228 
upper and lower airway in their responses to disease relevant stimuli (4, 14) in addition to 229 
alterations in the cellular composition of the airway epithelium down the tracheobronchial tree. 230 
We suggest that our technique is broadly applicable to a range of airway cells grown on 231 
standard transwell support systems,  and thus could be used to compare the metabolic profile 232 
of airway epithelial cells collected from different regions of the airway as well as comparisons 233 
between health and disease.  234 
This method also has transferability across other disease models where cells are grown on 235 
Transwell inserts, in particular where there is also a close association between altered glucose 236 
metabolism and disease risk (5, 15, 17). In principle this technique would open up additional 237 
avenues for metabolic research beyond epithelial monocultures, such as co-cultures with 238 
fibroblasts which also undergo significant metabolic shifts in disease-relevant conditions (22). 239 
This would support development of novel therapeutic strategies for targeting epithelia-240 
fibroblast crosstalk in idiopathic pulmonary fibrosis and related fibrotic interstitial lung 241 
diseases. Furthermore, because human variability is greater than that of animal models often 242 
used to study a disease, individual ex vivo metabolic profiling of the airway using our methods 243 
could provide vital information for personalized medicine (10). Such research could provide 244 
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much needed translational insights and facilitate the development of novel therapeutic 245 
approaches. 246 
We maintain that using ALI cultures is more physiologically relevant than using submerged 247 
cells, indicating the need for a method to transfer ALI cultures into the Seahorse Analyzer 248 
platform. The ALI cultures are highly differentiated, secretory, have motile cilia and therefore 249 
are more likely to recapitulate the complex metabolic requirements of airway epithelial cells in 250 
vivo. Basal epithelial cells, maintained in submerged culture, have a much lower rate of 251 
glycolysis and mitochondrial respiration than those grown at ALI (27) and therefore are not 252 
truly representative of in vivo airways. Furthermore, there are cell types which only become 253 
apparent when cells are maintained at ALI (20). Thus, using this novel methodology the 254 
Seahorse Analyzer is able to detect the integrated signal from the multiple cell types which 255 
are present in ALI cultures. This allows for the in vitro modelling of a physiologically 256 
heterogeneous whole airway epithelium rather than a single cell type. 257 
 258 
We were able to show that in high, but physiologically relevant glucose conditions, ALI cultures 259 
significantly increased the glycolysis dependent extracellular acidification rate.  In vivo we 260 
believe that this could result in an acidification of the airway surface liquid (ASL). Recent 261 
research has suggested that the precise regulation of the ASL, in particular the pH, has a 262 
critical role in the prevention of infection and disease pathology (9, 11, 24). Therefore the real 263 
time monitoring of pH and glucose metabolism, using platforms such as the Seahorse 264 
Analyzer, may be a key methodology for providing insights into the pathophysiology of airways 265 
disease and for therapeutic development. This may be especially relevant in situations where 266 
diabetes often represents an important comorbidity such as in cystic fibrosis, chronic 267 
obstructive pulmonary disease, and bronchiectasis.  268 
 269 
As well as providing novel information relevant to the pathophysiology of airways disease, our 270 
study demonstrated proof of concept that cellular bioenergetics analysis of differentiated 271 
epithelia may provide insights in pharmaceutical development.  A range of pathophysiological 272 
Downloaded from journals.physiology.org/journal/ajplung (086.186.050.195) on May 15, 2020.
13 
 
 
conditions including cancer and fibrotic lung diseases are thought to involve a reprograming 273 
of cellular metabolism, with skewing towards aerobic glycolysis, suggesting a potential 274 
therapeutic target. We showed that the addition of a potent LDH5 inhibitor resulted in a dose 275 
dependent reduction in extracellular acidification rate, consistent with a reduction in the 276 
production of lactate from pyruvate (22). Our system therefore allowed the evaluation of a 277 
novel compound in fully differentiated human cells, with the observed metabolic effects 278 
predicted from its designed mode of action.  279 
 280 
In conclusion, we present a novel method and supporting data to demonstrate that it is 281 
possible to monitor the cellular metabolism in real time of fully ALI differentiated airway 282 
epithelial cells. The method also allowed us to monitor cellular responses to altered glucose 283 
concentrations, which may be relevant where diabetes and airway hyperglycemia can present 284 
as comorbidities to chronic airways diseases. We also found that it is possible to manipulate 285 
epithelial cell metabolism with a novel small molecule, indicating that this method may be 286 
useful for evaluating future therapeutic drug candidates. 287 
 288 
 289 
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Figure legends 296 
Figure 1. Nasal epithelial ALI culture characterisation. A) Hematoxylin and eosin stain, TEM 297 
and SEM images of apical side of ALI culture. Scale bars indicate 10µm. B) Short circuit 298 
current trace from Ussing chamber experiment of ALI culture showing conventional airway 299 
epithelial responses to amiloride, forskolin, CFTRinh172 (all at 10 uM) and ATP (100 uM).  300 
Chemical modulators were applied sequentially to the apical compartment of the Ussing 301 
chamber. ISC Short circuit current. 302 
Figure 2. Schematic representation of ALI culture in Seahorse islet capture plate. 303 
Figure 3. Protocol optimisation for Seahorse XF24 Analyzer. A) Comparison of ALI cultures 304 
loaded into Islet capture plate with cells facing up or down in 10mM D-Glucose. Bar graphs 305 
indicate basal levels of OCR and ECAR, before injection of any drugs. Error bars indicate 306 
mean ± SEM for 7-9 replicates and p values shown calculated by unpaired t test. B) 307 
Oligomycin titration, left - OCR measurements normalised to last time point before addition 308 
of oligomycin, right - area under the curve analysis of OCR, error bars indicate mean ± SEM 309 
for 5-7 replicates and p values calculated by one way ANOVA. C) FCCP titration, left OCR 310 
normalised to last time point before addition of FCCP, right maximum OCR in each well 311 
following addition of FCCP, error bars indicate mean ± SEM for 5-6 replicates and p values 312 
calculated by one way ANOVA. 313 
Figure 4. Metabolic profiling of ALI cells at altered glucose concentrations. A) ECAR (left) 314 
and OCR (right) normalised to last reading before addition of glucose. Data from 4-6 repeats 315 
at each glucose concentration for 4 donors. Error bars indicate mean ± SEM. B) Absolute 316 
ATP production rates (left) and ATP production as a percentage of source, p values 317 
calculated by 2 way ANOVA (4-6 repeats at each glucose concentration from 6 donors). C) 318 
Dose dependent change in maximum ECAR before and after addition of LDH5inhibitor, all at 319 
15 mM D glucose (3-5 repeats at each glucose concentration from 2 donors). D) Change in 320 
maximum ECAR following addition of 30 µM LDH5 inhibitor at 1 mM, 5 mM and 15 mM D 321 
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glucose, normalised to the average of control wells without inhibitor, p values calculated by 322 
Mann-Whitney test (4-6 repeats at each glucose concentration from 3 donors).  323 
  324 
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Figure 1 – Nasal epithelial ALI culture characterisation
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Figure 2 –ALI culture in seahorse plate
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Figure 3 – Protocol optimisation
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Figure 4 – Metabolic profiling of ALI cells at altered glucose 
concentration
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